Cell Separator and Isolation Equipment

Added: Aug 07, 2017 1:15 pm
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Miltenyi Biotech Inc. to procure The autoMACS® Pro Separator and the gentleMACSTM Octo Dissociator.

This equipment will be used in support of ongoing research experiments performed in the Vaccine Research Center for vaccine production for HIV-1 and other viruses. Place of delivery is Bethesda, MD 20892.

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-B-1863524) to Laura Grey at laura.grey@nih.gov, by 5:00 pm eastern standard time August 16, 2017. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.